364 related articles for article (PubMed ID: 25210194)
1. The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.
Lemaître C; Harper F; Pierron G; Heidmann T; Dewannieux M
J Virol; 2014 Dec; 88(23):13626-37. PubMed ID: 25210194
[TBL] [Abstract][Full Text] [Related]
2. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
3. Prolonged activity of HERV-K(HML2) in Old World Monkeys accounts for recent integrations and novel recombinant variants.
Chabukswar S; Grandi N; Tramontano E
Front Microbiol; 2022; 13():1040792. PubMed ID: 36532485
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
5. A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion.
Lemaître C; Tsang J; Bireau C; Heidmann T; Dewannieux M
PLoS Pathog; 2017 Jun; 13(6):e1006451. PubMed ID: 28651004
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci.
Grandi N; Pisano MP; Scognamiglio S; Pessiu E; Tramontano E
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340287
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
[TBL] [Abstract][Full Text] [Related]
8. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
9. Genomic flexibility of human endogenous retrovirus type K.
Dube D; Contreras-Galindo R; He S; King SR; Gonzalez-Hernandez MJ; Gitlin SD; Kaplan MH; Markovitz DM
J Virol; 2014 Sep; 88(17):9673-82. PubMed ID: 24920813
[TBL] [Abstract][Full Text] [Related]
10. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.
Belshaw R; Dawson AL; Woolven-Allen J; Redding J; Burt A; Tristem M
J Virol; 2005 Oct; 79(19):12507-14. PubMed ID: 16160178
[TBL] [Abstract][Full Text] [Related]
11. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses.
Dewannieux M; Blaise S; Heidmann T
J Virol; 2005 Dec; 79(24):15573-7. PubMed ID: 16306628
[TBL] [Abstract][Full Text] [Related]
12. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C
PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390
[TBL] [Abstract][Full Text] [Related]
14. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
[TBL] [Abstract][Full Text] [Related]
18. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses.
Grandi N; Tramontano E
Front Immunol; 2018; 9():2039. PubMed ID: 30250470
[TBL] [Abstract][Full Text] [Related]
19. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.
Lavillette D; Marin M; Ruggieri A; Mallet F; Cosset FL; Kabat D
J Virol; 2002 Jul; 76(13):6442-52. PubMed ID: 12050356
[TBL] [Abstract][Full Text] [Related]
20. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
